Towards an evidence based perspective in advanced heart failure care M.C. DengG. BreithardtH.H. Scheld Editorial 01 October 1999 Pages: S001 - S004
Sympathetic activation in heart failure: A target of therapeutic approaches P. SchnabelM. Böhm OriginalPaper 01 October 1999 Pages: S005 - S011
Modulation of the renin-angiotensin-aldosterone system – pivotal in heart failure treatment W.J. Remme OriginalPaper 01 October 1999 Pages: S012 - S017
Chronic heart failure and cardiac cachexia and links between the endocrine and immune systems S.D. AnkerM. Cicoira OriginalPaper 01 October 1999 Pages: S018 - S023
Tumor necrosis factor-α in the failing human heart: Does it play a role in disease progression? G. Torre-AmioneS. StetsonK.A. Youker OriginalPaper 01 October 1999 Pages: S024 - S028
Outpatient intermittent dobutamine therapy in congestive heart failure F. OlivaE. GrondaB. Andreuzzi OriginalPaper 01 October 1999 Pages: S028 - S032
Prostaglandin E1 bridge to heart transplantation – methods, technique, results R. PacherB. Stanek OriginalPaper 01 October 1999 Pages: S033 - S035
Amiodarone and implantable cardioverter-defibrillators in congestive heart failure D. BöckerM. BlockG. Breithardt OriginalPaper 01 October 1999 Pages: S036 - S039
Growth hormone therapy in heart failure O. StrohmM.G. FriedrichR. Dietz OriginalPaper 01 October 1999 Pages: S040 - S046
Nursing care and education in heart failure U. Dahlström OriginalPaper 01 October 1999 Pages: S047 - S051